A survey of temocillin sensitivity of strains resistant to newer beta-lactam antibiotics.
The susceptibility of a total of 2014 Gram-negative clinical isolates (except Pseudomonas aeruginosa) to a number of antibiotics, including temocillin, was investigated in 2 geographically distinct areas. Overall, more strains were sensitive to temocillin than to mezlocillin, piperacillin, amoxycillin plus clavulanic acid, cefotaxime, cephazolin, latamoxef (moxalactam), cefoxitin, or netilmicin. Susceptibility to temocillin of multiple-resistant strains was studied.
D001424:Bacterial Infections / Q000382:microbiology; D002439:Cefotaxime / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D008802:Mezlocillin / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D009070:Moxalactam / Q000494:pharmacology; D010403:Penicillin Resistance; D010406:Penicillins / Q000494:pharmacology*; D010878:Piperacillin / Q000494:pharmacology
D010406:Penicillins; C031367:temocillin; D002439:Cefotaxime; D008802:Mezlocillin; D009070:Moxalactam; D010878:Piperacillin